BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 17682713)

  • 1. [Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
    Demirbileki M; Timurkaynak F; Can F; Azap O; Arslan H
    Mikrobiyol Bul; 2007 Apr; 41(2):261-9. PubMed ID: 17682713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
    Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
    Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela].
    Arcaya NM; Mesa LM; Pineda MR; Beltrán-Luengo H; Milagros Calvo B
    Rev Iberoam Micol; 2006 Jun; 23(2):97-100. PubMed ID: 16854186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
    Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
    Cordeiro RA; Teixeira CE; Brilhante RS; Castelo-Branco DS; Paiva MA; Giffoni Leite JJ; Lima DT; Monteiro AJ; Sidrim JJ; Rocha MF
    Med Mycol; 2013 Jan; 51(1):53-9. PubMed ID: 22712455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
    Arikan S; Sancak B; Hascelik G
    Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
    Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
    Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM; Prigitano A; Biraghi E; Viviani MA;
    J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
    New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
    Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG
    Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.